SeqDiagnostics is a molecular diagnostics company developing next-generation sequencing (NGS) assays to improve the detection and characterization of respiratory infections. Our flagship assay, NTM-Seq, provides rapid species-level identification and antimicrobial resistance insights for nontuberculous mycobacteria directly from respiratory samples, helping clinicians make more informed treatment decisions.
Roche Diagnostics
Explore our integrated Roche Sample Preparation Solutions, encompassing all the steps required to convert a sample to a sequencing-ready library. From sample collection to library quantification, we offer sample prep solutions for different sample types and sequencing applications that are proven, simple, and complete. | Roche provides innovative healthcare solutions focused on testing efficiency and medical value to face the challenges of today even as we anticipate the needs of tomorrow. Genentech, now a member of the Roche Group, is dedicated to pursuing groundbreaking science to discover and develop medicines for people with life-threatening diseases.
QuidelOrtho
QuidelOrtho develops and manufactures intelligent solutions that are transforming the power of diagnostics into a healthier future for all, helping spot trends sooner, respond quicker and chart the course ahead with accuracy and confidence. Together, we are transforming the power of diagnostics into a healthier future for all. | QuidelOrtho MicroVue Complement system products are a well-established name in immune system monitoring, providing a variety of first-in-class diagnostic and research solutions. The SPG product portfolio includes ELISA assays, multiplex, antibodies, proteins and sera-based products such as depleted sera, normal human serum and cobra venom factor.
Q-linea
At Q-linea, we design, develop, and deliver innovative infectious diseases diagnostic technology to improve patient outcomes and save lives. Our leading product, ASTar®, is a fully automated rapid AST system, direct from positive blood cultures. ASTar® produces results within approximately six hours and aims to reduce time to optimal therapy.
OraSure Technologies
OraSure Technologies, Inc. transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. OraSure improves access, quality, and value of healthcare with innovation in effortless tests and sample collection solutions. OraSure, together with its subsidiaries, DNA Genotek and Sherlock Biosciences, is a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Our portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, commercial entities, and direct to consumers. | We are committed to solving the world’s most complex testing challenges. Our legacy of innovation includes first-to-market rapid diagnostics for HIV, Hepatitis C, COVID-19 and Ebola, as well as oral fluid laboratory tests for detecting various drugs of abuse.
Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company’s more than 60,000 employees serve clients in over 100 countries, worked on over 80% of the new drugs approved by the FDA in 2022 and performed more than 600 million tests for patients around the world. Learn more about us at www.labcorp.com. | Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company’s nearly 70,000 employees serve clients in approximately 100 countries, provided support for more than 75% of the new drugs and therapeutic products approved in 2024 by the FDA, and perform more than 700 million tests annually for patients around the world. Learn more about us at www.labcorp.com. Invitae is a part of Labcorp. | We are a global life sciences and healthcare company harnessing science for human good. Every day, our mission is to improve health and improve lives. | Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company’s nearly 70,000 employees serve clients in approximately 100 countries, provided support for more than 75% of the new drugs and therapeutic products approved in 2024 by the FDA, and perform more than 700 million tests annually for patients around the world. Learn more about us at https://www.labcorp.com/infectious-disease.
Karius
Karius is a clinical metagenomics company focused on elevating patient care through microbial insights. We are committed to advancing diagnostic science and technology to optimize the diagnosis and treatment of infectious diseases.
IMMY
IMMY brings rapid, high-quality fungal diagnostics closer to the patient. We deliver accurate and affordable solutions that can be implemented in any laboratory setting around the world. IMMY is bridging the gap between fungal infections and proper treatment through rapid diagnostics for Aspergillosis, Cryptococcosis, Histoplasmosis, Coccidioidomycosis, and Blastomycosis.
Hardy Diagnostics
Founded in 1980 by Jay Hardy, Hardy Diagnostics remains committed to producing and distributing the finest products for the detection of microorganisms as the company partners with laboratory customers to diagnose and prevent disease. As an FDA licensed medical device manufacturer with Quality Management Systems certified to ISO 13485, Hardy Diagnostics manufactures over 2,700 products, including prepared and dehydrated culture media in all formats, rapid tests, reagents, custom culture media formulations, QuickSlide™ automated slide staining instruments, and more. With manufacturing facilities in both California and Ohio along with nine distribution centers strategically positioned across the United States, Hardy Diagnostics is committed to providing the utmost in speed and the highest quality products to meet the needs of the health care industry. As an employee owned company, rest assured that each Hardy Diagnostics team member has a personal interest in ensuring nothing but the best service and products are provided for its valued customers. | Hardy Diagnostics is an ISO 13485 certified, FDA licensed medical device manufacturer. This 100% employee owned company produces and distributes a full line of products to support Pharmaceutical quality compliance testing. The product offering includes the Trio.Bas microbial air samplers, aseptic technique verification kits for USP , culture media for environmental monitoring, sterility testing, and quality control organisms. Hardy Diagnostics also specializes in custom culture media requests, working alongside our pharmaceutical partners to ensure each product fits their specific testing needs.